Form 4: Atara Biotherapeutics Director Ameet Mallik Receives 150,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Director Ameet Mallik of Atara Biotherapeutics acquired 150,000 shares of restricted stock on March 31, 2024, which will vest at the company's 2025 annual meeting.

Summary

  • On March 31, 2024, Ameet Mallik, a director of Atara Biotherapeutics, acquired 150,000 shares of common stock.
  • These shares were acquired as restricted stock units at a price of $0 per share.
  • Following the transaction, Mallik directly owns 227,500 shares of Atara Biotherapeutics.
  • The restricted stock units will vest on the date of the Issuer's annual meeting of stockholders for the calendar year 2025, subject to the Reporting Person's continuous service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of restricted stock units to a director is a common practice and aligns their interests with shareholders. There are no indications of negative news or concerns.

Positives

  • The acquisition of restricted stock units by a director aligns their interests with those of the shareholders.
  • The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The vesting of the restricted stock units is contingent upon the director's continuous service, suggesting an expectation of continued involvement with the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a grant of equity compensation to a director, which is a common practice in the biopharmaceutical industry.

Comparison to Industry Standards

  • Equity compensation for board members is a common practice across the biotechnology industry.
  • Companies like Amgen, Gilead Sciences, and Biogen also grant stock options and restricted stock units to their directors as part of their compensation packages.
  • The amount of equity granted varies depending on the company's size, performance, and the director's role and responsibilities.

Stakeholder Impact

  • Shareholders: The grant of restricted stock units aligns the director's interests with those of the shareholders.
  • Employees: The grant of restricted stock units to a director can boost employee morale by demonstrating confidence in the company's future.

Key Dates

DateDescription
03/31/2024Date of transaction: Ameet Mallik acquired 150,000 shares of restricted stock.
04/02/2024Date of filing: Form 4 filing date.
2025Restricted stock units vest on the date of the Issuer's annual meeting of stockholders for the calendar year 2025, subject to the Reporting Person's continuous service.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.